Under My Thumb: Regulation and Healthcare Disruption
Some startups advance from dream to reality in a matter of months. In the heavily regulated life sciences industry, however, innovators and entrepreneurs face an uphill climb over hurdles that can be costly, uncertain, time-consuming, and in many cases terminal. This panel brings together diverse and sometimes opposing viewpoints--from a healthcare industry veteran, a former FDA regulator, and a healthcare venture investor--to explore why some healthcare ventures succeed where others fail.
Presenters
![Benjamin Wallfisch at SXSW](http://img.sxsw.com/2016/presenters/129534.jpg)
Benjamin Wallfisch
Sr Assoc
Norton Rose Fulbright
Ben Wallfisch counsels life sciences companies and healthcare providers in connection with enforcement and regulatory matters, including conducting internal investigations and defending clients tar...
Show the rest![Heather Rosecrans at SXSW](http://img.sxsw.com/2016/presenters/129546.jpg)
Heather Rosecrans
Exec VP of Medical Devices & Combination Products
Greenleaf Health LLC
Heather Rosecrans has more than 30 years of public health and medical device experience. She continues her commitment to public health by providing strategic consulting services and working with cl...
Show the restJames Eadie
Principal
Sante Ventures
James joined Santé Ventures in 2010. He focuses on medical device and health IT investing with particular focus on early stage technologies. He is on the boards of multiple companies including TVA ...
Show the restThomas Caven
VP Medical Affairs
Seton Healthcare Family
Dr Caven graduated summa cum laude from University of Texas at Austin, B.A. Plan II Honors Program. He completed his Medical Education at U.T. Medical School at San Antonio, where he was an A.O.A. ...
Show the rest